Trial Profile
Evaluation of the Absolute Bioavailability of Pegylated Interferon Alfa-2a After Subcutaneous Administration to Healthy Male Volunteers: An Open-Label, Randomized, Parallel-Group Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Roche
- 29 Aug 2012 New trial record